Atlas Trials

Alipogene Tiparvovec for the Treatment of LPLD Patients

Clinical trial NCT02904772 · WITHDRAWN

Trial details

NCT number
NCT02904772
Sponsor
UniQure Biopharma B.V.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
LPL Deficiency
Start date
2016-10-01
Primary completion
2020-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.